MetaVia, Inc. (MTVA) Projected Future Earnings
MetaVia Inc (MTVA) is developing methods for restoring neural connections in dementia, leveraging strict patent protection. The company is implementing cellular tissue regeneration to combat brain aging. Promising financial results demonstrate the trend of expected revenues, where the figure is fixed at . The current R&D pipeline focuses on biochemical therapy for cognitive impairment through intensive laboratory testing.
Comprehensive metric breakdowns and analytics for MetaVia (MTVA)
- price and consensus price forecast:
- market capitalization details:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- earnings and market ratios statistics:
MTVA - Net Financial Result|Expected Profit MetaVia Inc|MTVA - Price to Earnings Multiple|Forward P/E Multiple MetaVia Inc.|MTVA - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MetaVia|MTVA - Operating profit before deduction of amortization|Net earnings per share for the last 12 months MetaVia|MTVA - Earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months metaviatx.com|MTVA - Earnings per share growth in current year|Earnings growth forecast for next year MetaVia Inc
- sales volume and revenue information:
Initial company analysis:MetaVia Inc, MTVA
Issuer selection is based on a comparison of market capitalization with fundamental valuation multiples. This indicator reflects the consensus earnings forecast, neutralizing standard reporting lags through daily updates of expectations. For MetaVia Inc (MTVA), the calculation relies on the potential of exclusive patents in the treatment of neurodegeneration. Monopoly pricing power following clinical trials directly determines the dynamics of this metric. This revenue projection chart allows for an assessment of the future efficiency of such investments.
Main competitors
Expected Profit Biogen Inc.|Future Profit neurocrine.com (NBIX)|Projected Future Earnings RGC|AXSM - Expected Net Profit|ACADIA Pharmaceuticals Inc - Future Profit|Future Net Profit XENE (Xenon Corp)|Viking Therapeutics - Projected Future Earnings|SUPN - Projected Future Earnings|CPRX (Catalyst Pharmaceuticals, Inc.) - Future Profit|DNLI (Denali) - Expected Profit|HRMY (Harmony Pharma) - Projected Future Earnings|Biohaven Corp (BHVN) - Company Profit Forecast|Projected Future Earnings AMLX|Projected Future Earnings trevitherapeutics.com (TRVI)|Praxis Precision Medicines, Inc. - Future Profit|Expected Net Income AVXL|CeriBell Corp - Projected Future Earnings|Company Profit Forecast Prothena Corporation PRTA|alector.com (ALEC) - Expected Profit|Net Profit Forecast ANNX|OMER (Omeros Corp) - Projected Future Earnings|Future Profit Neurogene Inc (NGNE)|Expected Profit AC Immune Corp (ACIU)|Future Profit Voyager Corp VYGR|Neumora Therapeutics - Future Profit|Future Net Profit SCLX (scilexholding.com)|TVGN: Future Profit|ACOG: Expected Profit|CGTX: Projected Future Earnings|Inhibikase Pharma (IKT) - Projected Future Earnings|Expected Profit Cassava Sciences, Inc.|Net Profit Forecast ASRT (Assertio Therapeutics)|Projected Future Earnings COYA|VTGN - Expected Net Profit|Ovid Therapeutics - Future Profit|Projected Future Earnings Acumen Pharmaceuticals, Inc ABOS|CRVO - Expected Profit|Expected Net Income ATHE (Alterity Therapeutics)|clene.com (CLNN) - Expected Profit|Expected Net Profit PepGen (PEPG)|Expected Profit Jupiter Neurosciences|Future Profit Relmada Corp (RLMD)|Projected Future Earnings ANVS|GRCE - Expected Net Profit|Firefly Neuroscience - Future Profit|Future Net Profit KLTO (ANEW Medical)|NeuroSense Therapeutics, Ltd. - Projected Future Earnings|RVPH - Projected Future Earnings|NRXS (NeurAxis, Inc.) - Future Profit|HSDT (Helius Medical Technologies) - Expected Profit|PASG (Passage Bio Inc.) - Projected Future Earnings|Neuphoria (NEUP) - Company Profit Forecast|Projected Future Earnings NERV|Projected Future Earnings Athira Pharma Corp (ATHA)|Addex Therapeutics - Future Profit|Expected Net Income ALZN|Cyclerion - Projected Future Earnings|Company Profit Forecast Protagenic Therapeutics PTIX|pasitheaclinics.com (KTTA) - Expected Profit|Net Profit Forecast CRGT|ATXI (Avenue Therapeutics) - Projected Future Earnings|Future Profit brainstorm-cell.com (BCLI)|Expected Profit Cara Therapeutics (CARA)|Future Profit Chromocell Therapeutics Corp CHRO|Eliem Therapeutics Inc. - Future Profit|Future Net Profit ITCI (Intra-Cellular Therapies Inc.)|LBPH: Future Profit|MRNS: Expected Profit|NKGN: Projected Future Earnings|NeuroBo Pharmaceuticals Inc (NRBO) - Projected Future Earnings|Expected Profit Sage Therapeutics, Inc|Net Profit Forecast SNPX (Synaptogenix, Inc)|Projected Future Earnings TRVN|VIGL - Expected Net Profit|Anew Medical, Inc. - Future Profit|Projected Future Earnings Cerevel Therapeutics Inc CERE
